News Retroperitoneal Sarcoma Registry Date: September 30, 2018Author: Marco Fiore, MD 0 Comments Presently 38 institutions are partecipating, and 22 already recruting. Find here an update on the activation track of RESAR study. RESAR study (Retroperitoneal Sarcoma Registry) is an international observational study run by the TARPSWG. Condividi: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading... Related